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Shiga toxin producing bacteria are potential causes of serious human disease such as
hemorrhagic colitis, severe inﬂammations of ileocolonic regions of gastrointestinal tract,
thrombocytopenia, septicemia, malignant disorders in urinary ducts, hemolytic uremic
syndrome (HUS). Shiga toxin 1 (stx1), shiga toxin 2 (stx2), or a combination of both are
responsible for most clinical symptoms of these diseases. A lot of methods have been devel-
oped  so far to detect shiga toxins such as cell culture, ELISA, and RFPLA, but due to high costs
and  labor time in addition to low sensitivity, they have not received much attention. In this
study, PCR-ELISA method was used to detect genes encoding shiga toxins1 and 2 (stx1 and
stx2). To detect stx1 and stx2 genes, two primer pairs were designed for Multiplex-PCR then
PCR-ELISA. PCR products (490 and 275, respectively) were subsequently veriﬁed by sequenc-
ing. Sensitivity and speciﬁcity of PCR-ELISA method were determined by using genome
serial dilution and Enterobacteria strains. PCR-ELISA method used in this study proved to bea  rapid and precise approach to detect different types of shiga toxins and can be used to
detect bacterial genes encoding shiga toxins.
© 2015 Elsevier Editora Ltda. All rights reserved.Introduction
Shiga toxins belong to a large family of bacterial toxins with
two major groups, stx1 and stx2.1 These virulence factors
are mainly produced by Shigella dysenteriae and Shigatoxigenic
group of Escherichia coli like E. coli O157:H7 which are able
2,3to cause infectious diseases. The toxin is one of the AB5
toxins and has binding (B) and catalytic domains (A). The
pentameric B subunit of the toxin is responsible for receptor
∗ Corresponding author at: Applied Microbiology Research Center, Baqi
P.O.  Box 19395-5487, Tehran, Iran.
E-mail address: imanifouladi.a@gmail.com (A.A. Imani Fooladi).
http://dx.doi.org/10.1016/j.bjid.2015.02.008
1413-8670/© 2015 Elsevier Editora Ltda. All rights reserved.binding and intracellular trafﬁcking of the holotoxins.4 The
toxin binds to Gb3 located on cell surfaces and is introduced
by endocytic uptake. N-glycosidase activity of the A sub-
unit inhibits protein synthesis in the cell and causes cell
death.5 In some cells these toxins also trigger cytokine syn-
thesis and induce apoptosis, which is caused by ribotoxic
stress.6 The gene encoding toxin in Shigella dysenteriae isyatallah University of Medical Sciences, Vanak Sq. Molasadra St.,
chromosomal. However stx gene in E. coli O157:H7 is associ-
ated with a prophage.7 Different subtypes of shiga toxin are
identiﬁed as stx1, stx1c, stxfc, stx2, stx2e, stx2d and stx2g.8
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nfections by shiga toxins producing bacteria have world-
ide prevalence and are widespread in developing countries
uch as south-eastern Asian countries, Indian subcontinent,
outh Africa, central Asia, and Bangladesh.9 Infection of Shiga
oxin producing bacteria is a major health concern even
n developed countries all over the world. These bacteria
re potential cause of diarrhea, hemorrhagic colitis, severe
nﬂammations of ileocolonic regions of the gastrointestinal
ract, thrombocytopenia, septicemia, central nervous system
CNS) involvement, malignant disorders in urinary ducts, and
emolytic uremic syndrome (HUS).10 urinary tract infection
y EHEC is mainly generated by E. coli O157. In children under
ve years old and adults over 60, as they have the receptor,
t causes kidney function deﬁciency and has a death rate of
–10%.11 Cows, goats and other animals can naturally be a
ource of stx producing E. coli and other animals such as crabs
lso play a role in its transfer.12 Transfer between humans
an also take place.13 Since shiga toxins cause many  diseases,
specially in children and immunocompromised elderly peo-
le, a rapid and sensitive diagnostic method with prognostic
nformation would be rather useful. So far, many  different
etection methods such as cell culture, serological and molec-
lar methods such as RPLA, real-time, PCR, hybridization have
een utilized to detect shiga toxins or their respective genes.14
et, all these methods have their own shortcomings as they
re time-consuming, quite costly and have limitations in
andling many  samples simultaneously. At present, although
olecular methods such as PCR and hybridization, despite
eing less time-consuming, less costly, and more  sensitive,
hey are not suitable as they rely on agarose electrophore-
is with carcinogen ethidium bromide, a major health threat
or lab personnel, and does not allow analysis of many  sam-
les at a time in case of epidemic breakouts.15 Nevertheless,
eal-time PCR despite 100% speciﬁcity and high sensitivity has
ot gained much attention because of high costs of ﬂuores-
ent material and shortage of expert personnel.16 To overcome
hortcomings of the aforementioned methods, PCR-ELISA is
n appropriate alternative approach for detecting stx genes,
hich is safe and non-radioactive. PCR-ELISA is more  conve-
ient for rapid and reliable detection and quantiﬁcation of
athogen-speciﬁc gene sequences.17,18 Besides having been
sed in medical and food industries, PCR-ELISA has also been
sed in the veterinary industry.19
In this study, speciﬁc primers and probes for stx genes,
mpliﬁcation and labeling of products DIG-dUTP, hybridiza-
ion of streptavidin with biotinylated probes and detection
ith antibody against conjugated digoxigenin and peroxi-
ase in microtiter plates were designed. We identiﬁed speciﬁc
equences of stx genes in a large number of samples using
mall amounts simultaneously with considerable sensitivity
nd short turnaround time.
aterials  and  methods
acterial  strainshigella dysenteriae and E. coli O157:H7 strains were provided
rom Shahed University, Tehran, Iran and Pseudomonas aeru-
inosa, Salmonella typhimurium, Salmonella paratiphi, Klebsiella5;1 9(3):278–284 279
pneumonia and Vibrio cholera strains were provided by Baqiy-
atallah University of Medical Sciences, Tehran, Iran. The
strains were veriﬁed by biochemical and immunologic meth-
ods.
Extraction  of  bacterial  genomic  DNA
To extract genomic DNA from Shigella dysenteriae and E. coli
O157:H7 bacteria were incubated in liquid LB medium for 18 h
in 37 ◦C. Bacterial culture was centrifuged in 3000 rpm for
5 min. The pellet was resuspended in 300 L TE buffer followed
by lysis solution containing 10 L lysozyme (10 mg/mL), 200 L
SDS 20%, 3 L proteinase K and incubated in 37 ◦C for 60 min.
DNA was puriﬁed by extraction with an equal volume of phe-
nol/chloroform/isoamyl alcohol (25:24:1) in the presence of 5 M
sodium perchlorate. A 1/10 volume of 3 M sodium acetate and
2 volumes of absolute ethanol were added and incubated in
−20 ◦C for 13 h. The genome was pelleted by centrifugation,
washed with 70% ethanol and dried. Finally, DNA samples
were dissolved in 100 L TE buffer and, to eliminate RNA, 3 L
RNase A was added and the tubes were incubated in 37 ◦C for
30 min.
The concentration and purity of the DNA samples were
determined spectrophotometrically at A260 and A280 by Nan-
oDrop 2000, Thermo Scientiﬁc (USA).
Primer  and  probe  design
To design primers and the nucleic-acid sequencing probes,
central parts of shiga toxin genes were used as template. Fea-
tures in the designed primers such as GC content; Tm,  G, etc.
were checked by DNASIS and Oligo7 softwares. The primer
and probe sequences are illustrated in Table 1. The oligonu-
cleotides were supplied by CinnaClone (IRAN).
Isolation  and  ampliﬁcation  of  stx1  and  stx2  genes  by  PCR
PCR reagents in a ﬁnal volume of 25 L included: 1 L tem-
plate DNA, 0.5 L Taq DNA polymerase (5 U/L), 1 L of each
primer (10 pmol/L), 1 L dNTP mixture, 2.5 L 10× PCR buffer,
1.5 L MgCl2 (50 mM)  and 16.5 L sterile DDW. Thermal cycling
of ampliﬁcation mixture was performed in 30 cycles.20
The PCR program was carried out at 94 ◦C for 3 min  fol-
lowed denaturing for 45 s at 94 ◦C, annealing for 45 s at 59 ◦C
and an extension for 1 min  at 72 ◦C. The ﬁnal extension
was at 72 ◦C for 5 min. PCR products were electrophoresed
in 1% agarose followed by staining with ethidium bromide
(0.5 g/mL) then visualized under ultraviolet light, and the
results were recorded by photography. PCR products were ver-
iﬁed by sequencing. For labeling of PCR products, the reaction
of PCR was performed by dNTP mixture containing digoxi-
genin labeling mix  (Digoxigenin dNTPs, Roche, Germany) with
the same condition.
Detection  of  PCR  products  by  ELISAOne microgram avidin were coated on ELISA plates, one well
was placed as a negative control. Then, plates were washed
with PBS (pH 7.2) containing 0.05% Tween 20 (PBST) and the
blocked by 3% BSA buffer. In addition, 10 L of each labeled
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Table 1 – PCR primers and hybridization capture probe for stx1 and stx2 genes.
Oligonucleotide Sequence Nucleotide position Expect product size (bp)
Ah stx1F TTGTTTGCAGTTGATGTCAGAGG 210–233 275
Ah stx1R CAGGCAGGACACTACTCAACCTTC 676–700
Ah stx2F TTGCTGTGGATATACGAGGGC 214–235 490
Ah stx2R CGCCAGATATGATGAAACCAGTG 466–489
p Stx1 Biotin-TGTTGCAGGGATCAGTCGTACG 422–444 –
and stx1 genes respectively (Fig. 1b). The sizes of PCR products
were the same as predicted.
1 2 3 2 1
490bp
275bp
500bp
300bp
a bp Stx2 Biotin-CATATATCAGTGCCCGGTGTG 
product of stx1 and stx2 genes were added to 90 L 1× SSC
buffer in 1.5 mL  tubes and incubated in boiling water for 10 min
and then 5 min  on ice. In the next step, 10 L of stx1 and stx2
probes were added to each tube and after 2 h in 60 ◦C, 100 L
from this hybridization solution were added to each well and
after 1 h in 37 ◦C, it was washed with 20% BPST buffer 3 times. A
1/1000 solution of anti-digoxigenin antibody conjugated with
peroxides in PBST buffer was prepared and 100 L of this solu-
tion was added to each well (including controls) and after 1 h
in 37 ◦C the plates were washed and dried as described ear-
lier. 100 L of substrate solution (2 mg  OPD, 100 L detection
buffer, 5 L 30% hydrogen peroxide) was added to wells. 100 L
of 1 M H2SO4 was added to stop the reaction.21 The optical den-
sity was measured at 490 nm using an ELISA reader (Dynex
Technologies, Guornesey, Channel Islands and Great Britain).
Evaluation  PCR  speciﬁcity  and  sensitivity
To determine the speciﬁcity, PCR was carried out with genomic
DNA extracted from Pseudomonas aeruginosa, Salmonella
typhimurium, Salmonella paratiphi C, Klebsiella pneumonia and
Vibrio cholera. Products were analyzed on 1% agarose gel. To
determine the minimum genomic DNA concentration that
could be detected by the method, serially diluted genomic DNA
in TE buffer (pH = 8) was used as PCR template and the product
was analyzed on 1% agarose gel.
Sensitivity  evaluation  of  PCR-ELISA  technique  using
labeled  PCR  products  of  stx1  and  stx2
To determine the detection limit for stx gene, genomic
DNA was extracted and tenfold serial dilutions containing
108 ng/L to 0.108 pg/L and 156 ng/L to 0.156 pg/L of E. coli
O157:H7 and Shigella dysenteriae genomic DNA, respectively,
were prepared and all the steps were carried out as described
previously.22
PCR-ELISA  speciﬁcity  evaluation  using  bacterial  strains
To evaluate speciﬁcity of PCR-ELISA, E. coli O157:H7, Shigella
dysenteriae, Pseudomonas aeruginosa,  Salmonella typhimurium,
Salmonella paratiphi C and Klebsiella pneumonia strains were
grown in LB medium. Genomic DNAs were extracted and after
evaluating their concentration by NanoDrop, 10−2 fold dilution
was prepared as templates. The PCR was carried out accord-
ing to mentioned protocols and the products were analyzed
by agarose gel electrophoresis and ELISA.22355–376 –
Clinical  samples  analysis
In this study 63 positive samples of Shigella dysenteriae and
E. coli O157:H7 obtained from stool and urine cultures were
analyzed. Samples were gathered from Mazandaran hospitals
in a 3-month period between January and March of 2013. Age
groups included children between 8 months to 10 years old,
adults between 20 and 30 and between 50 and 90 years old
(Table 2). Samples were transferred to the lab, cultured, and
after growth were identiﬁed in differential and speciﬁc media
and veriﬁed by speciﬁc antiserums. Following DNA extraction
by boiling method, PCR-ELISA was carried out. Data analysis
was performed on SPSS.
Results
PCR
DNA from extracted genome of bacteria cultured in LB
medium was available in large quantities and was of good
quality. The purity of the DNA samples was conﬁrmed by
absorbance (A260/A280) ratio, which was 1.8–2.0. PCR was per-
formed for each strain with speciﬁc primers. Each PCR product
was  obtained as clear band at 275 and 490 bp generated by stx2Fig. 1 – Agarose gel electrophoresis of extracted E. coli
O157:H7 and Shigella dysenteriae genomic DNA and analysis
of PCR products. (a) Lane 1, E. coli O157:H7 genomic DNA;
Lane 2, Shigella dysenteriae’s genomic DNA. (b) Lane 1,
100 bp DNA ladder; Lane 2, PCR product (275 bp) for stx2;
Lane 3, PCR product (490 bp) for stx1.
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Table 2 – Clinical characteristics of patients.
Patient ID Age (years) Sex Type  of specimen Clinical manifestations Stx  genotype
Diarrhea Abdominal pain
2 30 F Bloody stool + + Stx1/Stx2
3 20 F Bloody stool + + Stx1/Stx2
8 8 M Bloody stool + + Stx1/Stx2
10 6 M Bloody stool + + Stx2
14 20 F Bloody stool + − Stx2
15 56 M Bloody stool + − Stx2
18 20 M Bloody stool + − Stx2
20 6 F Bloody stool + + Stx2
23 9 M Watery stool + − Stx2
27 8 M Bloody stool + + Stx1/Stx2
32 57 M Bloody stool + − Stx2
35 9 M Bloody stool + − Stx2
43 25 F Bloody stool + + Stx2
47 50 F Bloody stool + − Stx2
53 7 M Bloody stool + + Stx2
55 55 F Watery stool + − Stx2
59 8 M Bloody stool + − Stx2
a b
275bp
490bp
7 76 65 54 43 32 21 1
Fig. 2 – Speciﬁcity of PCR detection of E. coli O157:H7 (a) and Shigella dysenteriae (b). Lane 1, positive control; Lane 2, 100 bp
DNA ladder; Lane 3, Pseudomonas aeruginosa; Lane 4, Klebsiella pneumonia; Lane 5, Vibrio cholera; Lane 6, Salmonella
typhimurium; Lane 7, Salmonella paratyphi C.
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1peciﬁcity  of  PCRfter validation of PCR products, speciﬁcity of the reaction
as examined using genomes of Pseudomonas aeruginosa,
almonella typhimurium, Salmonella paratiphi C, Klebsiella pneu-
onia and Vibrio cholera. As shown in Fig. 2, no cross-reaction
1 3 5 6 7 84 2 a b
275bp
ig. 3 – Sensitivity of PCR detection using genomic DNA for E. col
adder; Lane 2, 10−1 dilution; Lane 3, 10−2 dilution; Lane 4, 10−3 d
0−6 dilution; Lane 8, 10−7 dilution.was found between the individual primers and non-target
pathogens in the PCR.Sensitivity  of  PCR
After preparing a serial dilution from E. coli O157:H7 and
Shigella dysenteriae at a primary concentration of 108 ng/L
1 3 5 6 7 842
490bp
i O157:H7 (a) and Shigella dysenteriae (b), Lane 1, 100 bp DNA
ilution; Lane 5, 10−4 dilution; Lane 6, 10−5 dilution; Lane 7,
282  b r a z j i n f e c t d i s . 2 0
490bp
275bp
1 2 3 4 5
Fig. 4 – Representative electrophoretic gels of PCR products
labeled with digoxigenin. Lane 1, 100 bp DNA ladder; Lane
2, PCR product of stx1 from Shigella dysenteriae genomic
DNA; Lane 3, PCR product of stx1 from Shigella dysenteriae
genomic DNA labeling with dNTP DIG mix; Lane 4, PCR
product of stx2 from E. coli O157:H7 genomic DNA; Lane 5,
PCR product of stx2 from E. coli O157:H7 genomic DNA
is not used in many  clinical labs.labeling with dNTP DIG mix.
and 156 ng/L, the PCR reactions were performed on these
dilutions and the results are displayed in Fig. 3. Regarding con-
centrations of the primary sample (108 ng/L and 156 ng/L),
sensitivity of the reaction was calculated as 1.08 pg/L and
1.56 pg/L, respectively.
Speciﬁc  PCR  with  dNTP  DIG  labeling  mix
A PCR reaction was performed with digoxigenin labeling mix
and the results were analyzed on 1% agarose gel (Fig. 4).
PCR-ELISA  speciﬁcity  and  sensitivity  assay
The speciﬁcity of the PCR-ELISA was analyzed using genomes
of Pseudomonas aeruginosa,  Salmonella typhimurium, Salmonella
paratiphi C, Klebsiella pneumonia and Vibrio cholera.
To determine the minimum detectable concentration of
genomic DNA of Shigella dysenteriae and E. coli O157:H7,
serial dilutions were subjected to the PCR-ELISA technique.
The results (Fig. 5) demonstrate the possibility of detecting
1.08 pg/L and 1.56 pg/L E. coli O157:H7 and Shigella dysente-
riae, respectively.
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Clinical  results
A total of 63 clinical samples were collected and screened for
the presence of E. coli O157:H7 and Shigella dysenteriae strains.
Seventeen (26.98%) samples were detected as stx positive.
Age distribution of the patients ranged from <1 to 90 years.
E. coli O157:H7 and Shigella dysenteriae infected patients had
an average age of 23.17 years, and 47.05% were less than
10 years old (Table 2). The most common symptoms were
bloody stools (88.23%) and abdominal pain (47.05%). Sex dis-
tribution of E. coli O157:H7 and Shigella dysenteriae infected
patients were 7 females (41.18%), and 10 males (58.82%). Bac-
teriological culture results were compared to those obtained
by PCR-ELISA. Results obtained from PCR-ELISA assay (Fig. 6)
and from selective culture were compared. There was a sig-
niﬁcant association between PCR-ELISA and culture results for
detecting and screening E. coli O157:H7 and Shigella dysenteriae.
(p < 0.001).
Discussion
Shiga toxin producing bacteria infection is a major health con-
cern even in developed countries all over the world.9,23,24 With
increasing reports of E. coli O157:H7 and Shigella dysenteriae
infections, great attention has been given to the development
of methods for detecting these pathogens and approaches for
prevention and treatment of these infections. This study was
intended to reach part of these aims.
In recent years, ELISA test has been designed to detect shiga
toxins directly in stool samples. The test is rapid and has a
good potential for shiga toxin detection since it can detect the
presence of shiga toxin-producing E. coli (STEC) or other shiga
toxin-producing bacteria. Since shiga toxin type differentia-
tion requires high cost monoclonal and polyclonal antibodies
it is not widely used. Hybridization method is an effective,
highly sensitive and speciﬁc molecular method for precise
detection of shiga toxins, and uses non-radioactive substances
such as digoxigenin and biotin. However, since it is not suit-
able for using in large number of clinical samples, this method
25In contrast to serological and microbiological tests, PCR
provides a rapid and sensitive alternative. This technique, ﬁrst
developed by Karch and Meyer, includes a primer pair from a
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Flso indicated. Assay cut-off was calculated by replicate ana
onserved region of stx1 and stx2 in homologous genes whose
ain defects were low Tm and ineffectiveness in different
ypes of shiga toxins.15 In that regard, to detect different types
f shiga toxins it is necessary to design a multiplex PCR with at
east two pairs of primers to detect shiga toxin gene. The ﬁrst
tudy on multiplex PCR detection shiga toxins was by Cebula
t al. who  designed speciﬁc primers and used a fragment as
ositive internal control. Nonetheless, primers were only able
o detect stx2.26 Subsequent studies were carried out by Paton
t al., Pass et al., Philot et al., and Belanger et al. Their main dis-
dvantage was that all fragments were low-size and were hard
o dissolve in agarose gel.14,27,28 The primers that we designed
or this study, after comparison with available data from gene
anks, using software and experiment on clinical samples,
roved to lack the above mentioned disadvantages and to be
ble of amplify different shiga toxin genes. In addition, these
mpliﬁed fragments were easily dissolved in agarose gel and
oth stx1 and stx2 genes could be simultaneously detected in
linical samples. One potential problem of PCR is the presence
f inhibitors, which may cause false results of the test. In Gram
egative bacteria different lipids, carbohydrates, and proteins
resent in cell wall can act as inhibitors and reduce the sensi-
ivity of the reaction.29 To overcome these limitations and to
ncrease sensitivity, bacterial genome must be puriﬁed before
arrying out the reaction. Frank et al. in 1998 used the boil-
ng method to extract genomic DNA; however, in this method
nhibitors could not be eliminated.30 Wang et al. in 2002 used
DS, lysozyme, tris, glucose and EDTA for extraction which
ncreased sensitivity to 100 pmol/L.31 In 2011, Marzony et al.
emoved inhibitors and extracted genomic DNA by using CTAB
nd 5 M NaCl and reported a sensitivity of 2.1 pg/L.32 Com-
aring PCR-ELISA with Vero cell assays, Fach et al.33 showed
hat results with PCR were obtained within 24 h whereas with
ero cell assays results were available only after ﬁve days.
urthermore, Beilei et al. developed PCR-ELISA methods to of negative samples (OD: 0.125).
detect Escherichia coli O157:H7 and other Shiga toxin-producing
E. coli (STEC) in food, where 105 CFU of STEC per gram of
ground beef detected without any culture enrichment by PCR-
ELISA.34
In this study, inhibitors were effectively eliminated by
using TE buffer, lysozyme, 20% SDS, proteinase K, RNase
A, 3 M Sodium Acetate and cold isopropanol. Consequently,
sensitivity of the test improved to 1.08 pg/L. PCR-ELISA
was successfully carried out with genomic DNA extracted
from clinical samples; from Shigella dysenteriae, a 490 bp frag-
ment was ampliﬁed as mentioned earlier. For E. coli O157:H7
both 490 and 275 bp fragments were ampliﬁed demonstrat-
ing that it can produce both toxins. PCR-ELISA correctly
conﬁrmed the speciﬁc stx1 and stx 2 genes. Non-positive
results for other strains indicate that the tests are highly
speciﬁc. Moreover, we  have compared the performance of
PCR-ELISA with standard agarose gel electrophoresis. PCR-
ELISA assay was more  sensitive than the gel electrophoresis.
Our data indicate that PCR-ELISA is highly speciﬁc, and
has higher sensitivity than conventional gel electrophoresis.
By offering shorter turnaround time and high sensitiv-
ity, PCR-ELISA has the potential to serve as a powerful
detection tool in medicine and in food and agricultural indus-
tries.
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